We are live on ! Find out more
FA

Fagan Associates Portfolio holdings

AUM $813M
1-Year Est. Return 37.92%
This Fund
S&P 500
This Quarter Est. Return
+4.83%
1 Year Est. Return
+37.92%
3 Year Est. Return
+110.01%
5 Year Est. Return
+134.08%
10 Year Est. Return
+676.44%
AUM
$428M
AUM Growth
+$29.5M
Cap. Flow
+$17M
Cap. Flow %
3.98%
Top 10 Hldgs %
39.79%
Holding
127
New
11
Increased
41
Reduced
59
Closed
2

Top Buys

Rank Stock Value
1
ALLY icon
Ally Financial
ALLY
+$3.75M
2
VRTX icon
Vertex Pharmaceuticals
VRTX
+$3.2M
3
GM icon
General Motors
GM
+$3.17M
4
TDOC icon
Teladoc Health
TDOC
+$3.14M
5
T icon
AT&T
T
+$2.87M

Top Sells

Rank Stock Value
1
ULTA icon
Ulta Beauty
ULTA
+$3.93M
2
UNH icon
UnitedHealth
UNH
+$3.81M
3
KL
Kirkland Lake Gold Ltd Ordinary
KL
+$2.61M
4
SCHG icon
Schwab US Large-Cap Growth ETF
SCHG
+$2.19M
5
META icon
Meta Platforms (Facebook)
META
+$2.17M

Sector Composition

Rank Sector Weight
1 Technology 21.61%
2 Consumer Discretionary 16.76%
3 Communication Services 13.09%
4 Financials 12.4%
5 Healthcare 5.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UFOX
26
Defiance Space and Connective Tech ETF
UFOX
$922M
$5.31M 1.24%
150,720
+2,495
+2% +$87.6K
EQIX icon
27
Equinix
EQIX
$106B
$5.07M 1.18%
7,455
-195
-3% -$134K
MRVL icon
28
Marvell Technology
MRVL
$199B
$4.75M 1.11%
96,970
-3,220
-3% -$158K
ARKG icon
29
ARK Genomic Revolution ETF
ARKG
$1.78B
$4.37M 1.02%
49,246
-229
-0.5% -$22.7K
BNDX icon
30
Vanguard Total International Bond ETF
BNDX
$83B
$4.12M 0.96%
72,135
+6,977
+11% +$403K
GM icon
31
General Motors
GM
$75.8B
$4.07M 0.95%
70,907
+59,697
+533% +$3.17M
ALLY icon
32
Ally Financial
ALLY
$13.6B
$4.06M 0.95%
+89,710
New +$3.75M
VRTX icon
33
Vertex Pharmaceuticals
VRTX
$131B
$3.93M 0.92%
18,285
+14,570
+392% +$3.2M
TDOC icon
34
Teladoc Health
TDOC
$1.26B
$3.8M 0.89%
20,892
+13,545
+184% +$3.14M
AGG icon
35
iShares Core US Aggregate Bond ETF
AGG
$138B
$3.79M 0.89%
33,266
+2,934
+10% +$340K
SCHD icon
36
Schwab US Dividend Equity ETF
SCHD
$108B
$3.78M 0.88%
155,355
-3,972
-2% -$90.3K
REGN icon
37
Regeneron Pharmaceuticals
REGN
$83B
$3.53M 0.83%
7,469
+702
+10% +$342K
NVDA icon
38
NVIDIA
NVDA
$5.46T
$3.51M 0.82%
263,240
-4,640
-2% -$62.4K
NVTA
39
DELISTED
Invitae Corporation
NVTA
$3.46M 0.81%
90,660
-1,380
-1% -$62.7K
BMY icon
40
Bristol-Myers Squibb
BMY
$132B
$3.43M 0.8%
54,333
+10,160
+23% +$632K
DAL icon
41
Delta Air Lines
DAL
$60B
$3.27M 0.76%
67,725
+330
+0.5% +$14.6K
FSLR icon
42
First Solar
FSLR
$24B
$3.15M 0.74%
36,085
-3,010
-8% -$276K
BND icon
43
Vanguard Total Bond Market
BND
$162B
$2.83M 0.66%
33,468
-575
-2% -$49.6K
VZ icon
44
Verizon
VZ
$200B
$2.8M 0.65%
48,111
+1,357
+3% +$76.6K
IOO icon
45
iShares Global 100 ETF
IOO
$9.46B
$2.76M 0.65%
41,825
+32
+0.1% +$2.08K
SCHP icon
46
Schwab US TIPS ETF
SCHP
$16.2B
$2.57M 0.6%
84,128
+46,530
+124% +$1.43M
SPY icon
47
State Street SPDR S&P 500 ETF Trust
SPY
$815B
$2.57M 0.6%
6,493
-13
-0.2% -$5.01K
PYPL icon
48
PayPal
PYPL
$51.8B
$2.5M 0.59%
10,317
+95
+0.9% +$24K
TRMB icon
49
Trimble
TRMB
$13.4B
$2.46M 0.57%
+31,570
New +$2.28M
SCHE icon
50
Schwab Emerging Markets Equity ETF
SCHE
$12.9B
$2.42M 0.57%
76,111
+7,677
+11% +$250K
1
2
3 4 5

Similar funds

KCP
Kera Capital Partners San Jose, California $815M AUM 46.39% 1-Year Est. Return
ACM
Ashford Capital Management Wilmington, Delaware $809M AUM 35.1% 1-Year Est. Return
BCM
Brigade Capital Management New York $806M AUM 20.71% 1-Year Est. Return
RIM
Redwood Investment Management Scottsdale, Arizona $805M AUM 15.01% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
VT
Volterra Technologies New York $823M AUM 28.93% 1-Year Est. Return
UM
Ulysses Management New York $802M AUM 5.35% 1-Year Est. Return
IAM
Infinitum Asset Management Fort Lauderdale, Florida $801M AUM 8.83% 1-Year Est. Return

Fagan Associates's Q1 2021 Portfolio in Review

As of Q1 2021, Fagan Associates held 127 positions worth $428M, up 7.4% from $398M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Fagan Associates deployed $17M of net new capital in Q1 2021, opening 11 new positions and adding to 41 existing holdings. Its largest new stake was Ally Financial: 89,710 shares worth $4.06M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Consumer Discretionary and Communication Services.

On the sell side, the largest reduction was Ulta Beauty, an estimated $3.93M trimmed.

  • Fagan Associates's largest Q1 2021 buy was Ally Financial: 89,710 shares worth $4.06M.
  • Fagan Associates added most to Vertex Pharmaceuticals in Q1 2021, an estimated $3.2M increase.
  • Fagan Associates's biggest Q1 2021 reduction was Ulta Beauty, cutting an estimated $3.93M.
  • Fagan Associates fully exited Kirkland Lake Gold Ltd Ordinary in Q1 2021, selling an estimated $2.61M.
  • Fagan Associates's ten largest holdings make up 40% of its $428M portfolio in Q1 2021.
  • Fagan Associates opened 11 new positions and closed 2 in Q1 2021.
  • Fagan Associates's portfolio value rose 7.4% quarter-over-quarter to $428M.

Based on Fagan Associates's 13F filing for Q1 2021, filed 6 May 2021.